These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37689398)

  • 1. Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis.
    Fumagalli C; Zampieri M; Argirò A; Tassetti L; Rossi G; Musumeci B; Tini G; Russo D; Sclafani M; Cipriani A; Sinigiani G; Di Bella G; Licordari R; Canepa M; Vianello PF; Merlo M; Porcari A; Rossi M; Sinagra G; Rapezzi C; Di Mario C; Ungar A; Olivotto I; Perfetto F; Cappelli F
    Int J Cardiol; 2023 Dec; 392():131346. PubMed ID: 37689398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Features of atrial fibrillation in wild-type transthyretin cardiac amyloidosis: a systematic review and clinical experience.
    Mints YY; Doros G; Berk JL; Connors LH; Ruberg FL
    ESC Heart Fail; 2018 Oct; 5(5):772-779. PubMed ID: 29916559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial Fibrillation in Transthyretin Cardiac Amyloidosis: Predictors, Prevalence, and Efficacy of Rhythm Control Strategies.
    Donnellan E; Wazni OM; Hanna M; Elshazly MB; Puri R; Saliba W; Kanj M; Vakamudi S; Patel DR; Baranowski B; Cantillon D; Dresing T; Jaber WA
    JACC Clin Electrophysiol; 2020 Sep; 6(9):1118-1127. PubMed ID: 32972546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis.
    Papathanasiou M; Jakstaite AM; Oubari S; Siebermair J; Wakili R; Hoffmann J; Carpinteiro A; Hagenacker T; Thimm A; Rischpler C; Kessler L; Rassaf T; Luedike P
    ESC Heart Fail; 2022 Jun; 9(3):1740-1748. PubMed ID: 35178887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality.
    Sanchis K; Cariou E; Colombat M; Ribes D; Huart A; Cintas P; Fournier P; Rollin A; Carrié D; Galinier M; Maury P; Duparc A; Lairez O;
    Amyloid; 2019 Sep; 26(3):128-138. PubMed ID: 31172799
    [No Abstract]   [Full Text] [Related]  

  • 6. Atrial fibrillation ablation in patients with transthyretin cardiac amyloidosis.
    Donnellan E; Wazni O; Kanj M; Elshazly MB; Hussein A; Baranowski B; Hanna M; Patel D; Trulock K; Martyn M; Menon V; Saliba W; Jaber WA
    Europace; 2020 Feb; 22(2):259-264. PubMed ID: 32031230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis.
    Porcari A; Rossi M; Cappelli F; Canepa M; Musumeci B; Cipriani A; Tini G; Barbati G; Varrà GG; Morelli C; Fumagalli C; Zampieri M; Argirò A; Vianello PF; Sessarego E; Russo D; Sinigiani G; De Michieli L; Di Bella G; Autore C; Perfetto F; Rapezzi C; Sinagra G; Merlo M
    Eur J Heart Fail; 2022 Jul; 24(7):1227-1236. PubMed ID: 35509181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine ambulatory heart rhythm monitoring for detection of atrial arrhythmias in transthyretin cardiac amyloidosis.
    Dale Z; Chandrashekar P; Al-Rashdan L; Gill S; Elman M; Fischer KL; Nazer B; Masri A
    Int J Cardiol; 2022 Jul; 358():65-71. PubMed ID: 35439584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Incidence of De Novo and Subclinical Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy and Cardiac Rhythm Management Device.
    Wilke I; Witzel K; Münch J; Pecha S; Blankenberg S; Reichenspurner H; Willems S; Patten M; Aydin A
    J Cardiovasc Electrophysiol; 2016 Jul; 27(7):779-84. PubMed ID: 27060297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced trans-mitral A-wave velocity predicts the presence of wild-type transthyretin amyloidosis in elderly patients with left ventricular hypertrophy.
    Yamamura S; Izumiya Y; Ishida T; Onoue Y; Kimura Y; Hanatani S; Araki S; Fujisue K; Sueta D; Kanazawa H; Takashio S; Usuku H; Sugamura K; Sakamoto K; Yamamoto E; Yamamuro M; Yasuda H; Kojima S; Kaikita K; Hokimoto S; Ogawa H; Tsujita K
    Heart Vessels; 2017 Jun; 32(6):708-713. PubMed ID: 27882404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catheter Ablation for Atrial Arrhythmias in Patients With Cardiac Amyloidosis.
    Tan NY; Mohsin Y; Hodge DO; Lacy MQ; Packer DL; Dispenzieri A; Grogan M; Asirvatham SJ; Madhavan M; McLEOD CJ
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1167-1173. PubMed ID: 27422772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial thrombo-embolic events in cardiac amyloidosis: a look beyond atrial fibrillation.
    Cappelli F; Tini G; Russo D; Emdin M; Del Franco A; Vergaro G; Di Bella G; Mazzeo A; Canepa M; Volpe M; Perfetto F; Autore C; Di Mario C; Rapezzi C; Musumeci MB
    Amyloid; 2021 Mar; 28(1):12-18. PubMed ID: 32981389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
    Ahmari SA; Bunch TJ; Chandra A; Chandra V; Ujino K; Daly RC; Kushwaha SS; Edwards BS; Maalouf YF; Seward JB; McGregor CG; Chandrasekaran K
    J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring.
    Fumagalli C; Bonanni F; Beltrami M; Ruggieri R; Zocchi C; Tassetti L; Maurizi N; Berteotti M; Zampieri M; Argirò A; Lovero F; Tomberli A; di Bari M; Marchionni N; Pieragnoli P; Ricciardi G; Checchi L; Cappelli F; Fumagalli S; Olivotto I
    Int J Cardiol; 2023 Jun; 381():70-75. PubMed ID: 37061097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiologic assessment of conduction abnormalities and atrial arrhythmias associated with amyloid cardiomyopathy.
    Barbhaiya CR; Kumar S; Baldinger SH; Michaud GF; Stevenson WG; Falk R; John RM
    Heart Rhythm; 2016 Feb; 13(2):383-90. PubMed ID: 26400855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation in cardiac resynchronization recipients with and without prior arrhythmic history. How much of arrhythmia is too much?
    Lenarczyk R; Jędrzejczyk-Patej E; Szulik M; Mazurek M; Podolecki T; Kowalczyk J; Kowalski O; Średniawa B; Kalarus Z;
    Cardiol J; 2015; 22(3):267-75. PubMed ID: 25563708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Susceptibility for Atrial Fibrillation in Patients Undergoing Atrial Fibrillation Ablation.
    Shoemaker MB; Husser D; Roselli C; Al Jazairi M; Chrispin J; Kühne M; Neumann B; Knight S; Sun H; Mohanty S; Shaffer C; Thériault S; Rinke LL; Siland JE; Crawford DM; Ueberham L; Zardkoohi O; Büttner P; Geelhoed B; Blum S; Aeschbacher S; Smith JD; Van Wagoner DR; Freudling R; Müller-Nurasyid M; Montgomery J; Yoneda Z; Wells Q; Issa T; Weeke P; Jacobs V; Van Gelder IC; Hindricks G; Barnard J; Calkins H; Darbar D; Michaud G; Kääb S; Ellinor P; Natale A; Chung M; Nazarian S; Cutler MJ; Sinner MF; Conen D; Rienstra M; Bollmann A; Roden DM; Lubitz S
    Circ Arrhythm Electrophysiol; 2020 Mar; 13(3):e007676. PubMed ID: 32078373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long-term efficacy of concomitant maze IV surgery in patients with atrial fibrillation.
    Engelsgaard CS; Pedersen KB; Riber LP; Pallesen PA; Brandes A
    Int J Cardiol Heart Vasc; 2018 Jun; 19():20-26. PubMed ID: 29946559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Ventilatory Efficiency Slope as a Marker for Increased Mortality in Wild-Type Transthyretin Cardiac Amyloidosis.
    Yunis A; Doros G; Luptak I; Connors LH; Sam F
    Am J Cardiol; 2019 Jul; 124(1):122-130. PubMed ID: 31053293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrical cardioversion of atrial arrhythmias with cardiac amyloidosis in the era of direct oral anticogulants.
    Touboul O; Algalarrondo V; Oghina S; Elbaz N; Rouffiac S; Hamon D; Extramiana F; Gandjbakhch E; D'Humieres T; Marijon E; Dhanjal TS; Teiger E; Damy T; Lellouche N
    ESC Heart Fail; 2022 Oct; 9(5):3556-3564. PubMed ID: 35903879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.